Product Information
Name:
Degarelix acetate
Synonyms:
- FE 200486
Description:
Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50= 3 nM in HEK293 cells expressing the human receptor), effective in inhibiting the growth of various prostate cell lines (WPMY-1, WPE1-NA22, BPH-1, and LNCaP) by activating caspase and inducing apoptosis after 72 hours of exposure to 10 μM. In vivo studies demonstrate that degarelix (2 mg/kg) significantly reduces plasma testosterone levels in rats to castrate levels for up to 49 days following administration, and reduces the tumor volume of Dunning R3327H prostate tumor flank implants when given at a dose of 1 mg/kg per month. Formulations of degarelix are utilized in the treatment of advanced prostate cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
1692.34
Formula:
C84H107ClN18O18
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
